|
Now Enrolling... The ChoICE Breast Cancer Cryoablation Clinical Trial Help Spread The Word
Dr. Holmes is now considering potential participants for the ChoICE Trial, a multicenter study evaluating cryoablation for the treatment of early-stage breast cancer in women age 70 and older. The trial will begin enrolling participants in August 2026.
The ChoICE Trial is a follow-up study to the landmark ICE3 Trial, which contributed to FDA approval of a breast cancer cryoablation device for selected patients with early-stage breast cancer. As a condition of FDA approval, IceCure Medical, the study sponsor, is conducting this 400-patient study.
The ChoICE Trial is open to women who meet the following criteria:
-70 years of age or older
-Diagnosis of invasive ductal carcinoma by core needle biopsy
-A single site of disease
-Tumor size equal to or less than 1.5 cm in greatest diameter as measured by breast ultrasound
-Estrogen receptor positive (ER+)
-Progesterone receptor positive (PR+)
-HER2 negative (HER2-)
-Favorable (low-risk) tumor biology (Ki-67 ,15%) or genomic testing showing low risk of recurrence (e.g., Mammaprint, Oncotype DX)
Cryoablation is performed under local anesthesia using ultrasound and a needle-like cryoprobe that freezes and kills the cancer with liquid nitrogen. The ChoICE trial requires a 5-year course of anti-estrogen after cryoablation. Radiation therapy and sentinel node biopsy are optional. A pioneer in breast cancer cryoablation with more than 20 years of cryoablation clinical and research experience, Dr. Holmes is pleased to launch the first west coast study site of this multicenter trial.
The cost of the cryoablation procedure will be billed to insurance or Medicare. However, if insurance does not cover the procedure, the cryoablation treatment will be provided at no cost to the patient. California residency is not required.
In addition to the ChoICE Trial, Dr. Holmes will continue to offer cryoablation to suitable patients outside of the trial.
For more information about ChoICE Trial eligibility or breast cancer cryoablation, contact us at info@cryoablation.com or www.cryoablation.com.
|